Cardinal Health Inc (CAH) Stock Forecast & Price Target
Cardinal Health Inc · NYSE
$232.61+3.26 (+1.42%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 13 firms covering Cardinal Health Inc, 12 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $186.00 to $275.00, a moderate spread. The average target of $240.50 sits 3% above the current $232.61. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.88 next quarter toward $12.05 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 ratings
Strong Buy
Strong Buy00%
Buy1292%
Hold18%
Sell00%
Strong Sell00%
Based on 13 analysts giving stock ratings to Cardinal Health Inc.
As of Jul, 12 of 13 firms rate CAH a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CAH EPS & revenue forecast
EPS · NEXT QUARTER
$2.88
Range $2.68 – $3.04 · 11 analysts · +13% YoY
Next period, 11 analysts expect Cardinal Health Inc to earn $2.88 a share (range $2.68 – $3.04), versus $2.55 a year earlier. , growing to $12.05 the year after.
REVENUE · NEXT QUARTER
$68.6B
Range $67.0B – $70.3B · 11 analysts · +7% YoY
Revenue is expected to reach $68.6B (range $67.0B – $70.3B), +7.2% year-over-year., rising to $276.5B next year.
Top analysts covering Cardinal Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CAH.
#1
Stephen Baxter
Wells Fargo
Buy
$245.00+5.3% to target
Coverage
—
+ Follow
#2
Daniel Grosslight
Citigroup
Buy
$245.00+5.3% to target
Coverage
—
+ Follow
#3
Steven Valiquette
Mizuho
Buy
$240.00+3.2% to target
Coverage
—
+ Follow
#4
Charles Rhyee
TD Cowen
Buy
$275.00+18.2% to target
Coverage
—
+ Follow
#5
GS
Glen Santangelo
Barclays
Buy
$258.00+10.9% to target
Coverage
—
+ Follow
CAH stock forecast FAQ
What is CAH's average 12-month price target?+
The 12 analysts with a live target average $240.50 for Cardinal Health Inc over the next 12 months, ranging from a $275.00 high to a $186.00 low.
Is CAH stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 13 analyst ratings, 12 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CAH?+
The Street-high target is $275.00 (TD Cowen), and the Street-low is $186.00 (Leerink Partners). The average of all 12 active targets is $240.50.
How many Wall Street analysts cover CAH?+
13 analysts have an active rating on Cardinal Health Inc, and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering CAH?+
Among analysts who currently cover CAH, Stephen Baxter of Wells Fargo has the strongest overall Quantellect track record. Their current call is Buy with a $245.00 target.
What is Cardinal Health Inc's projected EPS for next quarter?+
The consensus estimate is $2.88 per share (range $2.68 – $3.04) across 11 analysts, rising to $12.05 the following year.
How much revenue is Cardinal Health Inc expected to report next quarter?+
Consensus revenue is $68.6B (range $67.0B – $70.3B), growing to $276.5B next year.
Have analysts been upgrading or downgrading CAH lately?+
As of Jul, 12 of 13 firms rate CAH a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CAH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
